Birsfelden, Switzerland

Maike Lohrmann



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Maike Lohrmann

Introduction

Maike Lohrmann, an esteemed inventor based in Birsfelden, Switzerland, has made noteworthy contributions to the field of vermin deterrence. With a passion for innovation and a keen understanding of chemical compositions, Lohrmann has secured a patent that stands out in its effectiveness and practicality.

Latest Patents

Lohrmann's patent is titled "Composition for repelling and deterring vermin." This invention describes a non-therapeutical process focused on deterring vermin using known beta amino-alcohol derivatives of a specific formula. The patent outlines how these compounds can be formulated into effective compositions for repelling vermin, ensuring the protection of materials, environments, and warm-blooded animals from unwanted intruders.

Career Highlights

Currently, Maike Lohrmann is affiliated with Novartis AG, a global healthcare company renowned for its commitment to innovation in pharmaceuticals. During his time there, Lohrmann has demonstrated exceptional expertise in developing solutions to enhance public health and safety.

Collaborations

In his professional journey, Lohrmann has collaborated with talented colleagues such as Pierre Ducray and Tania Cavaliero. These collaborations highlight the importance of teamwork in driving successful innovations and advancements in their respective fields.

Conclusion

Maike Lohrmann's contributions to the science of vermin deterrence exemplify the power of innovative thinking and collaboration in the world of patents and inventions. His work not only protects our environments but also showcases the endless possibilities that arise from a commitment to research and development. As he continues his journey at Novartis AG, the potential for future innovations remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…